Next Financial Group’s Core Laboratories CLB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
$9K Hold
390
﹤0.01% 2212
2021
Q3
$11K Hold
390
﹤0.01% 1999
2021
Q2
$15K Sell
390
-139
-26% -$4.98K ﹤0.01% 1847
2021
Q1
$15K Hold
529
﹤0.01% 1731
2020
Q4
$14K Hold
529
﹤0.01% 1658
2020
Q3
$8K Buy
+529
New +$11.1K ﹤0.01% 1679
2020
Q2
Sell
-529
Closed -$5K 822
2020
Q1
$5K Sell
529
-258
-33% -$7.22K ﹤0.01% 1695
2019
Q4
$30K Buy
787
+201
+34% +$9.03K ﹤0.01% 1380
2019
Q3
$27K Buy
586
+2
+0.3% +$93 ﹤0.01% 1325
2019
Q2
$31K Buy
+584
New +$34.3K ﹤0.01% 1317
2019
Q1
Sell
-880
Closed -$53K 1688
2018
Q4
$53K Buy
880
+805
+1,073% +$69.5K 0.01% 785
2018
Q3
$9K Buy
+75
New +$8.46K ﹤0.01% 1004
2017
Q4
Sell
-425
Closed -$40K 449
2017
Q3
$40K Buy
425
+298
+235% +$28.9K 0.01% 760
2017
Q2
$13K Hold
127
﹤0.01% 1221
2017
Q1
$14K Sell
127
-775
-86% -$90.1K ﹤0.01% 1153
2016
Q4
$108K Hold
902
0.02% 651
2016
Q3
$101K Buy
902
+800
+784% +$92.1K 0.02% 659
2016
Q2
$12K Sell
102
-50
-33% -$6.04K ﹤0.01% 1134
2016
Q1
$17K Buy
152
+27
+22% +$2.81K 0.01% 996
2015
Q4
$13K Sell
125
-60
-32% -$6.87K ﹤0.01% 1079
2015
Q3
$18K Buy
185
+60
+48% +$6.53K 0.01% 984
2015
Q2
$14K Sell
125
-35
-22% -$4.24K ﹤0.01% 1139
2015
Q1
$16K Buy
160
+100
+167% +$10.7K 0.01% 1071
2014
Q4
$7K Sell
60
-285
-83% -$37.4K ﹤0.01% 1374
2014
Q3
$51K Buy
+345
New +$53.3K 0.01% 932

Other funds holding CLB

Next Financial Group's CLB Position: Q4 2021 in Review

Next Financial Group held its Core Laboratories (CLB) position steady in Q4 2021 at 390 shares worth $9K. The position accounts for ﹤0.01% of the portfolio, ranked #2212.

Next Financial Group first reported a position in CLB in Q3 2014 and has held it in 25 quarters since. The position peaked at $108K in Q4 2016. 174 funds tracked by Wall St. Rank hold CLB as of Q4 2021.

  • Next Financial Group held 390 shares of Core Laboratories worth $9K as of Q4 2021.
  • Next Financial Group left its Core Laboratories share count unchanged in Q4 2021.
  • Core Laboratories made up ﹤0.01% of Next Financial Group's portfolio in Q4 2021, its #2212 holding.
  • Next Financial Group first reported a position in Core Laboratories in Q3 2014 and has held it in 25 quarters since.
  • Next Financial Group's Core Laboratories position peaked at $108K in Q4 2016.
  • 174 funds tracked by Wall St. Rank held Core Laboratories as of Q4 2021.

Based on Next Financial Group's 13F filing for Q4 2021, filed 15 Feb 2022.